CD4 + CADM1 + cell percentage predicts disease progression in HTLV‐1 carriers and indolent adult T‐cell leukemia/lymphoma

Author:

Makiyama Junya1ORCID,Kobayashi Seiichiro2,Watanabe Eri3,Ishigaki Tomohiro45,Kawamata Toyotaka1,Nakashima Makoto6,Yamagishi Makoto6,Nakano Kazumi6,Tojo Arinobu12,Watanabe Toshiki17,Uchimaru Kaoru16

Affiliation:

1. Department of Hematology/Oncology Research Hospital, The Institute of Medical Science The University of Tokyo Tokyo Japan

2. Division of Molecular Therapy Advanced Clinical Research Center The Institute of Medical Science The University of Tokyo Tokyo Japan

3. IMSUT Clinical Flow Cytometry Laboratory The University of Tokyo Tokyo Japan

4. Department of Laboratory Medicine Research Hospital The Institute of Medical Science The University of Tokyo Tokyo Japan

5. Division of Stem Cell Therapy The Institute of Medical Science The University of Tokyo Tokyo Japan

6. Laboratory of Tumor Cell Biology Department of Computational Biology and Medical Sciences Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan

7. Future Center Initiative The University of Tokyo Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3